These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7732776)

  • 1. Increased CSF C4d in demyelinating neuropathy indicates the radicular involvement.
    Koguchi Y; Yamada T; Kuwabara S; Nakajima M; Hirayama K
    Acta Neurol Scand; 1995 Jan; 91(1):58-61. PubMed ID: 7732776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis.
    Tsuboi Y; Yamada T
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):859-61. PubMed ID: 8021681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy.
    Yamada T; Moroo I; Koguchi Y; Asahina M; Hirayama K
    Acta Neurol Scand; 1994 Jan; 89(1):42-6. PubMed ID: 8178627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
    J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP.
    Sivieri S; Ferrarini AM; Lolli F; Matà S; Pinto F; Tavolato B; Gallo P
    J Neurol Sci; 1997 Mar; 147(1):93-5. PubMed ID: 9094066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased intrathecal synthesis of prostaglandin D2 synthase in the cerebrospinal fluid of patients with acute inflammatory demyelinating polyneuropathy.
    Huang YC; Lyu RK; Tseng MY; Chang HS; Hsu WC; Kuo HC; Chu CC; Wu YR; Ro LS; Huang CC; Chen CM
    J Neuroimmunol; 2009 Jan; 206(1-2):100-5. PubMed ID: 19049845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies.
    Cornblath DR; Griffin JW; Tennekoon GI
    Ann Neurol; 1986 Sep; 20(3):370-2. PubMed ID: 2429614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebrospinal fluid findings in patients with acute and chronic inflammatory demyelinating polyradiculoneuropathies].
    Drulović J; Apostolski S; Stojasavljević N; Trikić R; Sokić D; Lević Z
    Srp Arh Celok Lek; 1996; 124(1-2):1-5. PubMed ID: 9102806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [4 cases of Guillain-Barré syndrome with axonal lesions].
    Vallat JM; Hugon J; Tabaraud F; Leboutet MJ; Chazot F; Dumas M
    Rev Neurol (Paris); 1990; 146(6-7):420-4. PubMed ID: 2399405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human endogenous local anesthetic-like factor (ELLF) is functionally neutralized by serum albumin.
    Aulkemeyer P; Brinkmeier H; Wollinsky KH; Rüdel R
    Neurosci Lett; 1996 Sep; 216(1):37-40. PubMed ID: 8892386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A significant correlation between cauda equina conduction time and cerebrospinal fluid protein in chronic inflammatory demyelinating polyradiculoneuropathy.
    Matsumoto H; Hanajima R; Terao Y; Hamada M; Shirota Y; Yugeta A; Nakatani-Enomoto S; Hashida H; Ugawa Y
    J Neurol Sci; 2018 Jan; 384():7-9. PubMed ID: 29249382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demyelinating involvement in Borrelian neuropathies].
    Clavelou P; Vernay D; Cuoq N; Soubrier M; D'Hombres A; Dordain G; Tournilhac M
    Rev Neurol (Paris); 1993; 149(5):320-5. PubMed ID: 8272726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.
    Harrington MG; Kennedy PG
    Postgrad Med J; 1987 Sep; 63(743):735-40. PubMed ID: 3328189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.
    Jongen PJ; Doesburg WH; Ibrahim-Stappers JL; Lemmens WA; Hommes OR; Lamers KJ
    Acta Neurol Scand; 2000 Feb; 101(2):116-21. PubMed ID: 10685859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunochemical findings in the cerebrospinal fluid in patients with inflammatory demyelinating polyradiculoneuropathy].
    Ivanisević V; Jovicić A; Mijusković Z; Magdić B
    Vojnosanit Pregl; 1989; 46(6):428-30. PubMed ID: 2631422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barré syndrome.
    Matà S; Galli E; Amantini A; Pinto F; Sorbi S; Lolli F
    Eur J Neurol; 2006 Feb; 13(2):153-60. PubMed ID: 16490046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid pheresis in Guillain Barré syndrome.
    Wollinsky KH; Hülser PJ; Westarp ME; Mehrkens HH; Kornhuber HH
    Med Hypotheses; 1992 Jun; 38(2):155-65. PubMed ID: 1528158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.
    Brettschneider J; Claus A; Kassubek J; Tumani H
    J Neurol; 2005 Sep; 252(9):1067-73. PubMed ID: 15789126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders.
    Rostami AM; Burns JB; Eccleston PA; Manning MC; Lisak RP; Silberberg DH
    Ann Neurol; 1987 Sep; 22(3):381-3. PubMed ID: 3674803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.